Sun-Ju Kong

Title: The Innovative Contributions of Sun-Ju Kong

Introduction

Sun-Ju Kong is a notable inventor based in Cheonan, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can inhibit the formation of microtubules. Her work is crucial in the fight against malignant tumors, showcasing her dedication to advancing medical science.

Latest Patents

Sun-Ju Kong holds a patent for benzophenone derivatives that are useful for inhibiting the formation of microtubules. The patent discloses novel benzophenone derivatives represented by a specific formula, along with their pharmaceutically acceptable salts, hydrates, or solvates. These compounds are part of a pharmacological composition that can be used as therapeutic drugs. The benzophenone derivatives exhibit inhibition activity of microtubule formation, making them valuable in treating the actively proliferating cells in malignant tumors.

Career Highlights

Sun-Ju Kong is associated with Chong Kun Dang Pharmaceutical Corporation, where she continues to innovate and contribute to pharmaceutical research. Her work has not only led to the development of new therapeutic options but has also positioned her as a key figure in her field.

Collaborations

Sun-Ju Kong collaborates with esteemed colleagues, including In-Taek Lim and Seung-Kee Moon. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Sun-Ju Kong's contributions to the field of pharmaceuticals, particularly through her patent on benzophenone derivatives, highlight her role as an influential inventor. Her work continues to pave the way for new treatments in oncology, demonstrating the impact of innovative research in medicine.